Nexalin Technology Inc (NXL)

Currency in USD
0.3610
-0.0190(-5.00%)
Closed·
0.3573-0.0037(-1.02%)
·
NXL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.36100.4000
52 wk Range
0.30502.0000
Key Statistics
Prev. Close
0.38
Open
0.3962
Day's Range
0.361-0.4
52 wk Range
0.305-2
Volume
108.06K
Average Volume (3m)
859.72K
1-Year Change
-62.3998%
Book Value / Share
0.14
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NXL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.0000
Upside
+454.02%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Nexalin Technology Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.0000
(+454.02% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy2.00+454.02%4.00Maintain07/04/2026

Earnings

Latest Release
08/05/2026
EPS / Forecast
-0.11 / -0.12
Revenue / Forecast
14.95K / 100K
EPS Revisions
Last 90 days

NXL Income Statement

Compare NXL to Peers and Sector

Metrics to compare
NXL
Peers
Sector
Relationship
P/E Ratio
−0.9x−2.7x−0.4x
PEG Ratio
−0.02−0.090.00
Price/Book
2.7x5.0x2.6x
Price / LTM Sales
28.2x2.9x3.0x
Upside (Analyst Target)
-66.7%50.7%
Fair Value Upside
Unlock14.0%6.5%Unlock

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
400.59K1.95%152.22K
Other Institutional Investors
669.24K3.25%254.31K
Public Companies & Retail Investors
19.51M94.80%7.41M
Total
20.58M100.00%7.82M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Peak6 Group LLC1.87%384,460146
Geode Capital Management, LLC1.20%247,03794

People Also Watch

1.85
RPGL
-7.04%
0.50
YMAT
-10.73%
39.4900
INHD
0.00%
3.1300
VRAX
+14.23%

FAQ

What Is the Nexalin Technology (NXL) Stock Price Today?

The Nexalin Technology stock price today is 0.3610 USD.

What Stock Exchange Does Nexalin Technology Trade On?

Nexalin Technology is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Nexalin Technology?

The stock symbol for Nexalin Technology is "NXL."

What Is the Nexalin Technology Market Cap?

As of today, Nexalin Technology market cap is 7.7800M USD.

What Is Nexalin Technology's Earnings Per Share (TTM)?

The Nexalin Technology EPS (TTM) is -0.4623.

When Is the Next Nexalin Technology Earnings Date?

Nexalin Technology will release its next earnings report on 02/09/2026.

From a Technical Analysis Perspective, Is NXL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nexalin Technology Stock Split?

Nexalin Technology has split 0 times.

How Many Employees Does Nexalin Technology Have?

Nexalin Technology has 8 employees.

What is the current trading status of Nexalin Technology (NXL)?

As of 03/07/2026, Nexalin Technology (NXL) is trading at a price of 0.3610 USD, with a previous close of 0.3800 USD. The stock has fluctuated within a day range of 0.3610 USD to 0.4000 USD, while its 52-week range spans from 0.3050 USD to 2.0000 USD.

What Is Nexalin Technology (NXL) Price Target According to Analysts?

The average 12-month price target for Nexalin Technology is 2.0000 USD, with a high estimate of 2 USD and a low estimate of 2 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +454.02% Upside potential.

What Is the NXL After Hours Price?

NXL's last after hours stock price is 0.3573 USD, the stock has decreased by -0.0037, or -1.0200%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.